Cartilage Degeneration Market Report: Trends, Forecast and Competitive Analysis to 2030
Get it in 2 to 4 weeks by ordering today
Cartilage Degeneration Trends and Forecast
The future of the global cartilage degeneration market looks promising with opportunities in the knee surgery and hip surgery markets. The global cartilage degeneration market is expected to reach an estimated $16.7 billion by 2030 with a CAGR of 11.5% from 2024 to 2030. The major drivers for this market are rise in the number of senior individuals, increasing incidence of musculoskeletal issues, and growth in the usage of advanced medical technologies.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Cartilage Degeneration by Segment
The study includes a forecast for the global cartilage degeneration by procedure type, treatment delivery channel, application, and region.
Cartilage Degeneration Market by Procedure Type [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cartilage degeneration companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cartilage degeneration companies profiled in this report include-
Lucintel forecasts that joint replacement will remain the largest segment over the forecast period due to advance technology and wide availability.
North America is expected to witness highest growth over the forecast period due to increasing prevalence of osteoarthritis and rheumatoid arthritis in the area owing to its aging population, presence of generous reimbursement policies and state-of-the-art healthcare infrastructure.
Features of the Global Cartilage Degeneration Market
Market Size Estimates: Cartilage degeneration market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Cartilage degeneration market size by procedure type, treatment delivery channel, application, and region in terms of value ($B).
Regional Analysis: Cartilage degeneration market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different procedure type, treatment delivery channel, application, and regions for the cartilage degeneration market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cartilage degeneration market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the cartilage degeneration market size?
Answer: The global cartilage degeneration market is expected to reach an estimated $16.7 billion by 2030.
Q2. What is the growth forecast for cartilage degeneration market?
Answer: The global cartilage degeneration market is expected to grow with a CAGR of 5.3% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the cartilage degeneration market?
Answer: The major drivers for this market are rise in the number of senior individuals, increasing incidence of musculoskeletal issues, and growth in the usage of advanced medical technologies.
Q4. What are the major segments for cartilage degeneration market?
Answer: The future of the global cartilage degeneration market looks promising with opportunities in the knee surgery and hip surgery markets.
Q5. Who are the key cartilage degeneration market companies?
Answer: Some of the key cartilage degeneration companies are as follows:
Answer: Lucintel forecasts that joint replacement will remain the largest segment over the forecast period due to advance technology and wide availability.
Q7. In cartilage degeneration market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to increasing prevalence of osteoarthritis and rheumatoid arthritis in the area owing to its aging population, presence of generous reimbursement policies and state-of-the-art healthcare infrastructure.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the cartilage degeneration market by procedure type (joint replacement, chondroplasty, osteochondral transplant, microfracture, meniscus transplant, cell based cartilage resurfacing, autologous chondrocyte implantation, others, , and), treatment delivery channel (hospital, academic & research institute, specialty clinic, ambulatory surgical center, and others), application (knee surgery , hip surgery, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Cartilage Degeneration Market, Cartilage Degeneration Market Size, Cartilage Degeneration Market Growth, Cartilage Degeneration Market Analysis, Cartilage Degeneration Market Report, Cartilage Degeneration Market Share, Cartilage Degeneration Market Trends, Cartilage Degeneration Market Forecast, Cartilage Degeneration Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
Cartilage Degeneration Trends and Forecast
The future of the global cartilage degeneration market looks promising with opportunities in the knee surgery and hip surgery markets. The global cartilage degeneration market is expected to reach an estimated $16.7 billion by 2030 with a CAGR of 11.5% from 2024 to 2030. The major drivers for this market are rise in the number of senior individuals, increasing incidence of musculoskeletal issues, and growth in the usage of advanced medical technologies.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Cartilage Degeneration by Segment
The study includes a forecast for the global cartilage degeneration by procedure type, treatment delivery channel, application, and region.
Cartilage Degeneration Market by Procedure Type [Shipment Analysis by Value from 2018 to 2030]:
- Joint Replacement
- Chondroplasty
- Osteochondral Transplant
- Microfracture
- Meniscus Transplant
- Cell Based Cartilage Resurfacing
- Autologous Chondrocyte Implantation
- Others
- Hospital
- Academic & Research Institute
- Specialty Clinic
- Ambulatory Surgical Center
- Others
- Knee Surgery
- Hip Surgery
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cartilage degeneration companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cartilage degeneration companies profiled in this report include-
- Zimmer Biomet Holdings
- Stryker
- Smith & Nephew
- B. Braun Melsungen
- Medtronic
- Johnson & Johnson
- Osiris Therapeutics
- Vericel
- Anika Therapeutics
- CONMED
Lucintel forecasts that joint replacement will remain the largest segment over the forecast period due to advance technology and wide availability.
North America is expected to witness highest growth over the forecast period due to increasing prevalence of osteoarthritis and rheumatoid arthritis in the area owing to its aging population, presence of generous reimbursement policies and state-of-the-art healthcare infrastructure.
Features of the Global Cartilage Degeneration Market
Market Size Estimates: Cartilage degeneration market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Cartilage degeneration market size by procedure type, treatment delivery channel, application, and region in terms of value ($B).
Regional Analysis: Cartilage degeneration market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different procedure type, treatment delivery channel, application, and regions for the cartilage degeneration market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cartilage degeneration market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the cartilage degeneration market size?
Answer: The global cartilage degeneration market is expected to reach an estimated $16.7 billion by 2030.
Q2. What is the growth forecast for cartilage degeneration market?
Answer: The global cartilage degeneration market is expected to grow with a CAGR of 5.3% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the cartilage degeneration market?
Answer: The major drivers for this market are rise in the number of senior individuals, increasing incidence of musculoskeletal issues, and growth in the usage of advanced medical technologies.
Q4. What are the major segments for cartilage degeneration market?
Answer: The future of the global cartilage degeneration market looks promising with opportunities in the knee surgery and hip surgery markets.
Q5. Who are the key cartilage degeneration market companies?
Answer: Some of the key cartilage degeneration companies are as follows:
- Zimmer Biomet Holdings
- Stryker
- Smith & Nephew
- B. Braun Melsungen
- Medtronic
- Johnson & Johnson
- Osiris Therapeutics
- Vericel
- Anika Therapeutics
- CONMED
Answer: Lucintel forecasts that joint replacement will remain the largest segment over the forecast period due to advance technology and wide availability.
Q7. In cartilage degeneration market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to increasing prevalence of osteoarthritis and rheumatoid arthritis in the area owing to its aging population, presence of generous reimbursement policies and state-of-the-art healthcare infrastructure.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the cartilage degeneration market by procedure type (joint replacement, chondroplasty, osteochondral transplant, microfracture, meniscus transplant, cell based cartilage resurfacing, autologous chondrocyte implantation, others, , and), treatment delivery channel (hospital, academic & research institute, specialty clinic, ambulatory surgical center, and others), application (knee surgery , hip surgery, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Cartilage Degeneration Market, Cartilage Degeneration Market Size, Cartilage Degeneration Market Growth, Cartilage Degeneration Market Analysis, Cartilage Degeneration Market Report, Cartilage Degeneration Market Share, Cartilage Degeneration Market Trends, Cartilage Degeneration Market Forecast, Cartilage Degeneration Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL CARTILAGE DEGENERATION MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Cartilage Degeneration Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Cartilage Degeneration Market by Procedure Type
3.3.1: Joint Replacement
3.3.2: Chondroplasty
3.3.3: Osteochondral Transplant
3.3.4: Microfracture
3.3.5: Meniscus Transplant
3.3.6: Cell based Cartilage Resurfacing
3.3.7: Autologous Chondrocyte Implantation
3.3.8: Other
3.4: Global Cartilage Degeneration Market by Treatment Delivery Channel
3.4.1: Hospital
3.4.2: Academic & Research Institute
3.4.3: Specialty Clinic
3.4.4: Ambulatory Surgical Center
3.4.5: Others
3.5: Global Cartilage Degeneration Market by Application
3.5.1: Knee Surgery
3.5.2: Hip Surgery
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Cartilage Degeneration Market by Region
4.2: North American Cartilage Degeneration Market
4.2.1: North American Cartilage Degeneration Market by Procedure Type: Joint Replacement, Chondroplasty, Osteochondral Transplant, Microfracture, Meniscus Transplant, Cell based Cartilage Resurfacing, Autologous Chondrocyte Implantation, and Others
4.2.2: North American Cartilage Degeneration Market by Application: Knee Surgery, Hip Surgery, and Others
4.3: European Cartilage Degeneration Market
4.3.1: European Cartilage Degeneration Market by Procedure Type: Joint Replacement, Chondroplasty, Osteochondral Transplant, Microfracture, Meniscus Transplant, Cell based Cartilage Resurfacing, Autologous Chondrocyte Implantation, and Others
4.3.2: European Cartilage Degeneration Market by Application: Knee Surgery, Hip Surgery, and Others
4.4: APAC Cartilage Degeneration Market
4.4.1: APAC Cartilage Degeneration Market by Procedure Type: Joint Replacement, Chondroplasty, Osteochondral Transplant, Microfracture, Meniscus Transplant, Cell based Cartilage Resurfacing, Autologous Chondrocyte Implantation, and Others
4.4.2: APAC Cartilage Degeneration Market by Application: Knee Surgery, Hip Surgery, and Others
4.5: ROW Cartilage Degeneration Market
4.5.1: ROW Cartilage Degeneration Market by Procedure Type: Joint Replacement, Chondroplasty, Osteochondral Transplant, Microfracture, Meniscus Transplant, Cell based Cartilage Resurfacing, Autologous Chondrocyte Implantation, and Others
4.5.2: ROW Cartilage Degeneration Market by Application: Knee Surgery, Hip Surgery, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Cartilage Degeneration Market by Procedure Type
6.1.2: Growth Opportunities for the Global Cartilage Degeneration Market by Treatment Delivery Channel
6.1.3: Growth Opportunities for the Global Cartilage Degeneration Market by Application
6.1.4: Growth Opportunities for the Global Cartilage Degeneration Market by Region
6.2: Emerging Trends in the Global Cartilage Degeneration Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Cartilage Degeneration Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cartilage Degeneration Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Zimmer Biomet Holdings
7.2: Stryker
7.3: Smith & Nephew
7.4: B. Braun Melsungen
7.5: Medtronic
7.6: Johnson & Johnson
7.7: Osiris Therapeutics
7.8: Vericel
7.9: Anika Therapeutics
7.10: CONMED
2. GLOBAL CARTILAGE DEGENERATION MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Cartilage Degeneration Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Cartilage Degeneration Market by Procedure Type
3.3.1: Joint Replacement
3.3.2: Chondroplasty
3.3.3: Osteochondral Transplant
3.3.4: Microfracture
3.3.5: Meniscus Transplant
3.3.6: Cell based Cartilage Resurfacing
3.3.7: Autologous Chondrocyte Implantation
3.3.8: Other
3.4: Global Cartilage Degeneration Market by Treatment Delivery Channel
3.4.1: Hospital
3.4.2: Academic & Research Institute
3.4.3: Specialty Clinic
3.4.4: Ambulatory Surgical Center
3.4.5: Others
3.5: Global Cartilage Degeneration Market by Application
3.5.1: Knee Surgery
3.5.2: Hip Surgery
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Cartilage Degeneration Market by Region
4.2: North American Cartilage Degeneration Market
4.2.1: North American Cartilage Degeneration Market by Procedure Type: Joint Replacement, Chondroplasty, Osteochondral Transplant, Microfracture, Meniscus Transplant, Cell based Cartilage Resurfacing, Autologous Chondrocyte Implantation, and Others
4.2.2: North American Cartilage Degeneration Market by Application: Knee Surgery, Hip Surgery, and Others
4.3: European Cartilage Degeneration Market
4.3.1: European Cartilage Degeneration Market by Procedure Type: Joint Replacement, Chondroplasty, Osteochondral Transplant, Microfracture, Meniscus Transplant, Cell based Cartilage Resurfacing, Autologous Chondrocyte Implantation, and Others
4.3.2: European Cartilage Degeneration Market by Application: Knee Surgery, Hip Surgery, and Others
4.4: APAC Cartilage Degeneration Market
4.4.1: APAC Cartilage Degeneration Market by Procedure Type: Joint Replacement, Chondroplasty, Osteochondral Transplant, Microfracture, Meniscus Transplant, Cell based Cartilage Resurfacing, Autologous Chondrocyte Implantation, and Others
4.4.2: APAC Cartilage Degeneration Market by Application: Knee Surgery, Hip Surgery, and Others
4.5: ROW Cartilage Degeneration Market
4.5.1: ROW Cartilage Degeneration Market by Procedure Type: Joint Replacement, Chondroplasty, Osteochondral Transplant, Microfracture, Meniscus Transplant, Cell based Cartilage Resurfacing, Autologous Chondrocyte Implantation, and Others
4.5.2: ROW Cartilage Degeneration Market by Application: Knee Surgery, Hip Surgery, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Cartilage Degeneration Market by Procedure Type
6.1.2: Growth Opportunities for the Global Cartilage Degeneration Market by Treatment Delivery Channel
6.1.3: Growth Opportunities for the Global Cartilage Degeneration Market by Application
6.1.4: Growth Opportunities for the Global Cartilage Degeneration Market by Region
6.2: Emerging Trends in the Global Cartilage Degeneration Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Cartilage Degeneration Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cartilage Degeneration Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Zimmer Biomet Holdings
7.2: Stryker
7.3: Smith & Nephew
7.4: B. Braun Melsungen
7.5: Medtronic
7.6: Johnson & Johnson
7.7: Osiris Therapeutics
7.8: Vericel
7.9: Anika Therapeutics
7.10: CONMED
